Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:5:p13
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 5 (pt 13/22)
Character Range: 284440–287434

to sunlight.
LINDANE in preparations containing 10% or less of lindane except when included in Schedule 2 or 4.
LOTILANER.
LUFENURON except:
 (a) in divided preparations each containing 500 mg or less of lufenuron for the treatment of animals; or
 (b) in single use syringes each containing 500 mg or less of lufenuron for the treatment of animals.
MACROPHOMINA PHASEOLINA except when used as a herbicide in capsule preparations at a concentration of 16 CFU or less per capsule.
MADURAMICIN in animal feed premixes containing 1% or less of antibiotic substances.
MAGNESIUM CHLORATE except in preparations containing 10% or less of magnesium chlorate.
MALACHITE GREEN in preparations for veterinary use containing 10% or less of malachite green.
MALATHION in preparations containing 10% or less of malathion except:
 (a) for human therapeutic use; or
 (b) in dust preparations containing 2% or less of malathion.
MANCOZEB.
MANDESTROBIN except in preparations containing 25% or less of mandestrobin.
MANDIPROPAMID.
MARJORAM OIL except:
 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert, and labelled with the warning:

           KEEP OUT OF REACH OF CHILDREN; or
 (c) in preparations containing 50% or less of marjoram oil.
MCPA:
 (a) in preparations containing 25% or less of MCPA (acid); or
 (b) in preparations containing 50% or less of the salts and esters of MCPA.
MEBENDAZOLE for the treatment of animals:
 (a) in divided preparations each containing 300 mg or less of mebendazole per dosage unit; or
 (b) in undivided preparations containing 25% or less of mebendazole.
MECLOFENAMIC ACID for the treatment of animals.
MECOPROP in preparations containing 2% or less of mecoprop.
MEFENPYR‑DIETHYL.
MEFENTRIFLUCONAZOLE except in preparations containing 7.5% or less of mefentrifluconazole.
MEPIQUAT.
MERCAPTAMINE in cosmetic preparations containing 6% or less of mercaptamine except in preparations containing 1% or less of mercaptamine.
MERCAPTOACETIC ACID and its salts, but excluding its derivatives, in cosmetic preparations containing 20% or less of mercaptoacetic acid or its salts (as mercapturic acid), except in preparations containing 5% or less of mercaptoacetic acid or its salts (as mercapturic acid)
MESOTRIONE.
METAFLUMIZONE.
METALAXYL in preparations containing 35% or less of metalaxyl.
METALDEHYDE in preparations containing 2% or less of metaldehyde.
METARYLPICOXAMID.
METAZACHLOR.
METHABENZTHIAZURON.
METHANOL (excluding its derivatives) in preparations containing 10 % or less of methanol except:
 (a) when included in Schedule 10; or
 (b) in preparations containing 2% or less of methanol; or
 (c)